First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT05817058 · TERMINATED
Trial details
- NCT number
- NCT05817058
- Sponsor
- Affimed GmbH
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2024-11-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.